Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Recro Pharma Inc, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced the signing of a development and ...
read more
Wednesday, January 26, 2022
Recro Pharma has been awarded a new formulation development and cGMP manufacturing contract from a key department of the United States government. The contract focuses on supporting clinical development of a topical dermal treatment for the ...
read more
Recursion, a clinical stage TechBio company decoding biology to industrialize drug discovery, launched Valence Labs which will serve as a machine learning research laboratory focused on developing the next generation of cutting-edge methods and ...
read more
Thursday, November 08, 2012
Following the launch of research, pharmaceutical development and manufacturing company Almac’s new recycling initiative in May 2012, the amount of recycled waste at Almac dramatically increased from 19% to 70% in just a couple of months, and has ...
read more
RedHill Biopharma has replaced its existing co-commercialization agreement with Daiichi Sankyo, for Movantik, which was assigned to RedHill under its April 2020 acquisition agreement with AstraZeneca.
read more
Wednesday, October 14, 2020
RedHill announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib.
read more
RedHill Biopharma Ltd. has announced the signing of a research collaboration agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), intended to evaluate RedHill’s ...
read more
Monday, February 01, 2021
RedHill Biopharma announced a manufacturing agreement with Cosmo Pharmaceuticals to further expand manufacturing capacity for opaganib.
read more
Friday, September 04, 2020
RedHill announced the selection of opaganib1 for severe COVID-19 pneumonia.
read more
RedHill Biopharma has entered into a binding term sheet with Cosmo Pharmaceuticals for an exclusive licensing and manufacturing agreement for multiple products.
read more
Redwire Corporation has opened a new 30,000 square foot, state-of-the-art research and microgravity payload development facility in Georgetown, Indiana, designed to accelerate space-enabled R&D and manufacturing with a focus on next-generation drug ...
read more
Thursday, December 03, 2020
Reed-Lane has introduced its second Track & Trace-ready cartoning line for unit-level serialization and multi-level aggregation.
read more
Wednesday, September 14, 2016
Reed-Lane, a New Jersey-based contract packaging provider that serves leading pharmaceutical manufacturers, has installed its sixth bottling line for solid dose RX and OTC products.
read more
Tuesday, January 15, 2019
Reed-Lane has officially entered the cold supply chain market with the opening of its first controlled cold storage at its Wayne, NJ packaging facility.
read more
Reed-Lane has added a dedicated room for vial and ampule kitting to its cold chain capabilities.
read more